Citi analyst Mathieu Chevrier maintained a Sell rating on Nanosonics Limited (NNCSF – Research Report) today and set a price target of A$3.90. The company’s shares closed last Monday at $2.83.
Chevrier covers the Healthcare sector, focusing on stocks such as CSL, Ramsay Health Care, and Ansell. According to TipRanks, Chevrier has an average return of -3.9% and a 21.43% success rate on recommended stocks.
The word on The Street in general, suggests a Hold analyst consensus rating for Nanosonics Limited with a $2.80 average price target.
See today’s best-performing stocks on TipRanks >>
NNCSF market cap is currently $858.1M and has a P/E ratio of 63.88.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Nanosonics Limited (NNCSF) Company Description:
Nanosonics Ltd is an Australia based healthcare equipment manufacturing company. It manufactures and distributes the trophon EPR ultrasound probe disinfector, which reduces the risk of ultrasound-related cross-infection. It also manufactures the associated consumables and accessories such as the trophon wall mount, trophon printer, trophon cart, trophon curved probe positioner and others. In addition, the company manufactures and commercializes infection control and decontamination products and services and related technologies. The entity operates in Australia and other countries, of which key revenue is derived from North America.
